Dataset on the reproductive health needs of women receiving opioid substitution treatment and the role of community pharmacy

This dataset consists of anonymised transcripts of two series of semi-structured interviews conducted between 2016 and 2017 in south-west and south-east England.

The first series was conducted with 20 community pharmacists who supply opioid substitution and provide the supervised administration service. Most interviews were conducted face to face, but a few were conducted by telephone. They were undertaken to understand pharmacists' knowledge of the reproductive health needs of women who are receiving opioid substitution treatment and whether the pharmacists felt able, and were willing to provide, reproductive health support and if so, what that should look like.

The second series was conducted with 40 women of child bearing age (18–49, ethics precluded recruiting younger participants) receiving opioid substitution treatment, recruited through community drug teams in south-west and south-east England. The interviews were conducted face to face. They were undertaken to understand women's reproductive health needs when they are receiving opioid substitution treatment and whether they felt a community pharmacy would be an acceptable place to receive reproductive health support. The transcripts also include demographics such as age, number of previous pregnancies, length of time receiving opioid substitution treatment (OST) and type of OST.